Bringing Greater Accuracy to Europe’s Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology
Rapid and continuing advances in biomarker testing are not being matched by take-up in health systems, and this is hampering both patient care and innovation. It also risks costing health systems the opportunity to make their services more efficient and, over time, more economical. This paper sets o...
Similar Items
-
Case Report: Whole exome sequencing identifies a novel frameshift insertion c.1325dupT (p.F442fsX2) in the tyrosine kinase domain of BTK gene in a young Indian individual with X-linked agammaglobulinemia [version 2; referees: 2 approved]
by: Amit Rawat, et al.
Published: (2017-08-01) -
Gene length and detection bias in single cell RNA sequencing protocols [version 1; referees: 2 approved]
by: Belinda Phipson, et al.
Published: (2017-04-01) -
A one-step, one-tube real-time RT-PCR based assay with an automated analysis for detection of SARS-CoV-2
by: Bhasker Dharavath, et al.
Published: (2020-07-01) -
Diagnosing tuberculosis in the 21st century – Dawn of a genomics revolution?
by: Christopher Jeanes, et al.
Published: (2016-01-01) -
Genomic Testing for Human Health and Disease Across the Life Cycle: Applications and Ethical, Legal, and Social Challenges
by: Gemma A. Bilkey, et al.
Published: (2019-03-01)